Description
Studies show Lactospore to help reduce symptoms of IBS, regulate cholesterol, reverse canker sores, and support immune function.
Lactobacillus sporogenes was isolated from green malt in 1949, by Japanese researchers, and was later reclassified as Bacillus coagulans. Bacillus coagulans (marketed as Lactospore) is a shelf stable (at room temperature) probiotic, with clinically documented efficacy in supporting health and wellness. Lactospore works on restoring gastrointestinal balance through competitive inhibition of pathogens, the production of L-(+) lactic acid and hydrogen peroxide, and production of bacteriocins, a sort of natural antibiotic that suppresses the growth of putrefactive bacteria. Being in spore form, this culture survives and proliferates in the gastrointestinal environment more easily than most other probiotics. Lactospore also produces only the beneficial L-(+) form of lactic acid in the gastrointestinal tract, unlike some other probiotics that also produce D-(-) form of lactic acid, which has been associated with metabolic acidosis. Clinical efficacy of Lactospore has been shown in the management of gastrointestinal problems associated with infections, or the use of antibiotics. Conditions include diarrheal diseases and constipation, as studied in populations of all ages, including infants, and promising results in the management of allergic skin diseases (eczema) in infants, were observed.
Reviews
There are no reviews yet.